Europeans face extreme inequality in access to diagnosis and treatment for lung cancer, a report published this week revealed. Experts have called for a harmonised approach to cancer care and greater efforts to promote preventive policies.
The European Commission is on track to miss its target of decreasing cancer deaths by 15% by 2020. But a focus on thrombosis, the subject of a global awareness campaign today, could turn things around.
Organisations of patients with rare diseases have warned EU policymakers to “think carefully” before reviewing the incentives in the orphan drugs regulation, claiming that the pharma industry should not be discouraged from investing in new therapies.
The European Medicines Agency approved 39 new cancer drugs between 2009 and 2013 despite having no evidence that they worked, unnecessarily exposing patients to toxicity, researchers said Thursday (5 October).
The European Parliament’s environment committee objected to the Commission’s proposed criteria for endocrine disruptors on Thursday (28 September), and threw out another objection to the executive’s proposal to regulate levels of cancer-causing acrylamide in food.
The European Parliament’s environment committee will vote on Thursday (28 September) on a resolution which seeks to stop a Commission proposal to regulate levels of carcinogenic acrylamide in food, amid continuing pleas from food safety advocates to endorse the original proposal.
Governments across Europe have applied ever-more restrictive measures to the sale of food and drinks as a way of fighting obesity – a regulatory proliferation that is making retailers worried about new barriers to the EU’s single market.